Article

Kvantify, a quantum technology scaleup based in Aarhus, has completed a second closing of a €7 million funding round. The investment from the European Innovation Council Fund and Delphinus Venture Capital will accelerate the development of technology that merges quantum and classical computing for drug development.

Kvantify's Qrunch technology, launched in November 2025, allows for quantum chemistry applications on real quantum computers. The company aims to enhance collaboration with drug discovery organizations and strengthen its market position in quantum integration, which could significantly reduce drug development costs and improve outcomes.